Thomas Clozel
Directeur Général chez Owkin France SASU
Provenance du réseau au premier degré de Thomas Clozel
Entité | Type d'entité | Industrie | |
---|---|---|---|
Owkin, Inc.
Owkin, Inc. Packaged SoftwareTechnology Services Owkin, Inc. operates as an artificial intelligence company. It develops software which allow prediction modeling and population comparison services. The firm's products include OWKIN Socrates and OWKIN Services. The company was founded by Thomas Clozel and Gilles Wainrib in 2016 and is headquartered in Albany, NY.
4
| Holding Company | Packaged Software | 4 |
Owkin France SASU
Owkin France SASU Medical/Nursing ServicesHealth Services Owkin France SAS provides artificial intelligence for predictive medicine. The company was founded on September 7, 2016 and is headquartered in Paris, France.
3
| Subsidiary | Medical/Nursing Services | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Thomas Clozel via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Vantia Ltd.
Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Vantia Ltd. services to provide molecule agonists of vasopressin receptors. It offers healthcare improve clinical treatments through development and commercialization of innovative medicines. The company was founded by Robert Haigh and Chris Yea in 2008 and is headquartered in Southampton, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
EM Lyon Business School | College/University | Undergraduate Degree | |
Heriot-Watt University | College/University | Graduate Degree | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
US Oncology, Inc.
US Oncology, Inc. Medical/Nursing ServicesHealth Services US Oncology, Inc. engages in the provision of cancer care servicers. It offers therapies, depending on such things as type of cancer, stage at diagnosis and the patient’s overall health such as chemotherapy, radiotherapy, surgery, hormone therapy, and immunotherapy. The company was founded in 1999 and is headquartered in The Woodlands, TX. | Medical/Nursing Services | Chief Executive Officer | |
Ecole Polytechnique | College/University | Undergraduate Degree | |
École Nationale Supérieure des Mines de Paris | College/University | Undergraduate Degree | |
COFACE SA | Specialty Insurance | Director/Board Member | |
Econocom France SAS
Econocom France SAS Electronics DistributorsDistribution Services Econocom France SAS wholesales computer, peripherals and software products. The company is headquartered in Clichy, France. | Electronics Distributors | Corporate Officer/Principal | |
Compagnie Française d'Assurance pour le Commerce Extérieur SA
Compagnie Française d'Assurance pour le Commerce Extérieur SA Multi-Line InsuranceFinance Compagnie Française d'Assurance pour le Commerce Extérieur SA is a holding company, which provides credit insurance and related services. Its offers debt collection, bonds, factoring, and business information. The company was founded in August 7, 2000 and is headquartered in Bois-Colombes, France. | Multi-Line Insurance | Director/Board Member | |
AstraZeneca SAS
AstraZeneca SAS Pharmaceuticals: MajorHealth Technology AstraZeneca SAS researches, develops, produces, and commercializes pharmaceutical products. It offers solutions in different domains such as cardio-vascular, metabolism, oncology, respiratory, and inflammatory diseases. The company was founded on April 21, 1955 and is headquartered in Courbevoie, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
TXCELL | Miscellaneous Commercial Services | Director/Board Member | |
POXEL | Pharmaceuticals: Major | Director/Board Member | |
Université de Bordeaux | College/University | Doctorate Degree | |
BIOM'UP | Medical Specialties | Director/Board Member | |
International Institute for Management Development | College/University | Masters Business Admin | |
GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member | |
VOLUNTIS S.A. | Packaged Software | Director/Board Member | |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Corporate Officer/Principal | |
Dynacure SA
Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Director/Board Member | |
DNA Script SAS
DNA Script SAS Medical SpecialtiesHealth Technology DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
TreeFrog Therapeutics SAS
TreeFrog Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services TreeFrog Therapeutics SAS provides stem cell treatment services. It offers its expertise to patients of heart failure, diabetes, traumatic injury, skin burns, dermatitis, Huntington, and Parkinson disease. The company was founded by Maxime Feyeux, Kevin Alessandri, Jean-Luc Treillou, Erwan Bezard, Laurent Cognet, and Pierre Nassoy and is headquartered in Pessac, France. | Miscellaneous Commercial Services | Director/Board Member | |
BPIFrance Investissement SAS
BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Investor | |
CancerLinQ LLC
CancerLinQ LLC Data Processing ServicesTechnology Services CancerLinQ LLC is a real-world oncology data platform developed by ASCO that collects and aggregates longitudinal electronic health record data from oncology practices throughout the world. The non-profit company is based in Alexandria, VA. The platform aims to improve the quality of patient care and accelerate discovery by securely compiling, harmonizing, analyzing, and de-identifying vast amounts of information on patient characteristics, treatments, and long-term side effects. By using data from nearly 7 million patient records in near real-time, CancerLinQ can improve health outcomes for all patients with cancer and advance evidence-based research. The company was founded in 2014. The CEO is Sean Khozin. | Data Processing Services | Chief Executive Officer | |
University of Maryland | College/University | Undergraduate Degree | |
George Washington University School of Medicine & Health | College/University | Graduate Degree | |
University of Maryland School of Medicine | College/University | Doctorate Degree | |
Hello Health, Inc.
Hello Health, Inc. Internet Software/ServicesTechnology Services Part of PracticeSuite, Inc., Hello Health, Inc. is an American digital health solutions company that aims to provide a leading ecosystem for managing health in a cost-effective and convenient way. The company offers an electronic health record, practice management system, patient portal, and telehealth solution. With over 34 million unique monthly users, the company is a clear leader in health and wellness content development to drive consumer and patient engagement. The company was founded by Sean Khozin, and the CEO is Pamela Wirth. Hello Health was acquired by PracticeSuite, Inc. from Myca Health Inc. on August 12, 2021. | Internet Software/Services | Founder | |
Université de Montpellier | College/University | Doctorate Degree | |
Permira Advisers LLP
Permira Advisers LLP Investment ManagersFinance Permira Advisers LLP (Permira Advisers) is a private equity subsidiary of Permira Holdings Ltd founded in 1985 by Peter M. Smitham. The firm is headquartered in London, United Kingdom with additional offices in the United States and Asia. | Investment Managers | Consultant / Advisor | |
University of Cambridge | College/University | Doctorate Degree | |
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | Biotechnology | Director/Board Member | |
First Cambridge Gateway LP | Investment Managers | Chief Investment Officer | |
OC&C | Consultant / Advisor | ||
MVM Partners LLP
MVM Partners LLP Investment ManagersFinance MVM Partners LLP (MVM Partners) is a venture capital firm founded in 1997. The firm is headquartered in London, the United Kingdom. | Investment Managers | Private Equity Investor | |
Xention Pharma Ltd.
Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Acacia Pharma Ltd.
Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
ACACIA PHARMA GROUP PLC | Pharmaceuticals: Other | Director/Board Member | |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Chief Executive Officer | |
ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
F-Prime UK Ltd.
F-Prime UK Ltd. Miscellaneous Commercial ServicesCommercial Services F-Prime UK Ltd. was founded in 2007 and provides strategy development, market research, investment advisory, and administration support services. The private company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
Tenpoint Therapeutics Ltd.
Tenpoint Therapeutics Ltd. BiotechnologyHealth Technology Tenpoint Therapeutics Ltd. is a British biotechnology company that specializes in developing engineered cell-based therapies and in vivo reprogramming to restore vision for individuals with degenerative ocular diseases. The company is based in Cambridge, UK and was founded in 2020. Tenpoint Therapeutics brings together experts who are shaping the regenerative ocular medicine revolution and the technologies that are driving it. The company's focus is on replacing diseased cells with healthy ones to permanently restore vision. Eddy Anglade has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
Impresa Management LLC (United Kingdom) | Investment Managers | Private Equity Investor | |
Ciwit BV
Ciwit BV Internet Software/ServicesTechnology Services Ciwit BV provides electronic data capture platform for medical research. The company was founded by Derk Arts in 2011 and is headquartered in Amsterdam, the Netherlands. | Internet Software/Services | Director/Board Member | |
Oviva AG
Oviva AG Miscellaneous Commercial ServicesCommercial Services Oviva AG provides online medical nutritional counseling services. Its dietitians provide treatment and care services for various medical problems in adult and pediatric populations, such as obesity, type 1 and type 2 diabetes, high blood sugar, heart disease and stroke, digestive diseases, and allergy and intolerances directly in GP and specialist clinics, as well as remotely. The company was founded in 1999 and is headquartered in Schwyz, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
VERSITY | Real Estate Development | Director/Board Member | |
Gateway Fund Co. Pte Ltd. | Corporate Officer/Principal |
Statistiques
Internationale
France | 23 |
Royaume-Uni | 17 |
Etats-Unis | 8 |
Suisse | 4 |
Pays-Bas | 2 |
Sectorielle
Health Technology | 16 |
Consumer Services | 12 |
Finance | 10 |
Commercial Services | 6 |
Technology Services | 5 |
Opérationnelle
Director/Board Member | 31 |
Corporate Officer/Principal | 11 |
Independent Dir/Board Member | 6 |
Chief Executive Officer | 5 |
Undergraduate Degree | 5 |
Relations les plus connectées
Insiders | |
---|---|
Alexander Pasteur | 19 |
Laurent Higueret | 14 |
Martin Gouldstone | 12 |
Bruno Strigini | 10 |
Isabelle Laforgue | 8 |
Sean Khozin | 7 |
Gilles Wainrib | 2 |
- Bourse
- Insiders
- Thomas Clozel
- Connexions Sociétés